Literature DB >> 1648812

Pediatric cytomegalovirus infection.

W J Britt1, R F Pass, S Stagno, C A Alford.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1648812

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

1.  Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro.

Authors:  R Snoeck; G Andrei; D Schols; J Balzarini; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

2.  Cytomegalovirus (CMV) infection in AIDS patients is associated with a CD3 receptor-mediated T cell hyporesponsiveness.

Authors:  A W Rowbottom; M W Lepper; D Sharpstone; B Gazzard
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

3.  Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps to UL27.

Authors:  Gloria Komazin; Roger G Ptak; Brian T Emmer; Leroy B Townsend; John C Drach
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Selective impairment of T lymphocyte activation through the T cell receptor/CD3 complex after cytomegalovirus infection.

Authors:  M Timón; A Arnaiz-Villena; J Ruiz-Contreras; J T Ramos-Amador; A Pacheco; J R Regueiro
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Lungs are a major organ site of cytomegalovirus latency and recurrence.

Authors:  M Balthesen; M Messerle; M J Reddehase
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo.

Authors:  J Neyts; F Stals; C Bruggeman; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267

7.  Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice.

Authors:  J Neyts; H Sobis; R Snoeck; M Vandeputte; E De Clercq
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

8.  Role of a mutation in human cytomegalovirus gene UL104 in resistance to benzimidazole ribonucleosides.

Authors:  Gloria Komazin; Leroy B Townsend; John C Drach
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56.

Authors:  P M Krosky; M R Underwood; S R Turk; K W Feng; R K Jain; R G Ptak; A C Westerman; K K Biron; L B Townsend; J C Drach
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.